HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,050
-400 (-2.59%)
Aug 8, 2025, 3:30 PM KST
-2.59%
Market Cap216.95B
Revenue (ttm)36.10B
Net Income (ttm)472.66M
Shares Out14.04M
EPS (ttm)34.13
PE Ratio459.01
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume166,571
Average Volume101,876
Open15,250
Previous Close15,450
Day's Range15,020 - 15,770
52-Week Range15,050 - 33,250
Beta0.31
RSI27.50
Earnings Daten/a

About Six Flags Entertainment

HLB Pharmaceutical Co., Ltd., a pharmaceutical company, researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dent... [Read more]

Sector Healthcare
Founded 1998
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 047920
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.